Nexgel (NXGLW) Income from Continuing Operations (2018 - 2025)
Nexgel's (NXGLW) quarterly Income from Continuing Operations came in at 928000.0 in Q4 2025, down 12.62% YoY from 1062044.44 in Q4 2024, and down 43.43% on a QoQ basis from 647000.0 in Q3 2025.
Nexgel (NXGLW) Income from Continuing Operations (2018 - 2025) Analysis & Trends
Nexgel (NXGLW) has 8 years of Income from Continuing Operations data on file, last reported at 928000.0 in Q4 2025.
- Quarterly Income from Continuing Operations fell 12.62% year-over-year to 928000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 2893000.0 (up 16.44% YoY) and the FY2025 annual result came in at 2285000.0, up 19.06% from the prior year.
- Income from Continuing Operations slipped to 928000.0 in Q4 2025, from 647000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 552000.0 in Q3 2023 to a low of 1836000.0 in Q1 2022.
- A 5-year average of 936300.0 and a median of 825000.0 in 2021 frame the typical range for Income from Continuing Operations.
- The widest YoY moves for Income from Continuing Operations: up 63.29% in 2022, down 160.8% in 2022.
- Tracing NXGLW's Income from Continuing Operations over 5 years: stood at 1765000.0 in 2021, then jumped by 63.29% to 648000.0 in 2022, then slumped by 83.18% to 1187000.0 in 2023, then surged by 30.58% to 824000.0 in 2024, then fell by 12.62% to 928000.0 in 2025.
- The last three Income from Continuing Operations figures came in at 928000.0 (Q4 2025), 647000.0 (Q3 2025), and 640000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | -3.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -928,000.00 |
| Sep 30, 2025 | -647,000.00 |
| Jun 30, 2025 | -640,000.00 |
| Mar 31, 2025 | -678,000.00 |
| Dec 31, 2024 | -824,000.00 |
| Sep 30, 2024 | -754,000.00 |
| Jun 30, 2024 | -979,000.00 |
| Mar 31, 2024 | -905,000.00 |
| Dec 31, 2023 | -1.19 Mn |
| Sep 30, 2023 | -552,000.00 |
| Jun 30, 2023 | -642,000.00 |
| Mar 31, 2023 | -807,000.00 |
| Dec 31, 2022 | -648,000.00 |
| Sep 30, 2022 | -1.23 Mn |
| Jun 30, 2022 | -1.04 Mn |
| Mar 31, 2022 | -1.84 Mn |
| Dec 31, 2021 | -1.77 Mn |
| Sep 30, 2021 | -1.14 Mn |
| Jun 30, 2021 | -826,000.00 |
| Mar 31, 2021 | -704,000.00 |